Pegaptanib sodium - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for pegaptanib sodium and what is the scope of freedom to operate?

Pegaptanib sodium is the generic ingredient in one branded drug marketed by Bausch And Lomb Inc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for pegaptanib sodium

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	1
Clinical Trials:	34
Patent Applications:	4,574
DailyMed Link:	pegaptanib sodium at DailyMed

Recent Clinical Trials for pegaptanib sodium

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Vision Research Foundation	Phase 2
Greater Houston Retina Research	Phase 3
Postgraduate Institute of Medical Education and Research	Phase 4

See all pegaptanib sodium clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for pegaptanib sodium

S01LA	Antineovascularisation agents
S01L	OCULAR VASCULAR DISORDER AGENTS
S01	OPHTHALMOLOGICALS
S	Sensory organs

US Patents and Regulatory Information for pegaptanib sodium

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bausch And Lomb Inc	MACUGEN	pegaptanib sodium	INJECTABLE;INTRAVITREAL	021756-001	Dec 17, 2004		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for pegaptanib sodium

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bausch And Lomb Inc	MACUGEN	pegaptanib sodium	INJECTABLE;INTRAVITREAL	021756-001	Dec 17, 2004	⤷ Sign Up	⤷ Sign Up
Bausch And Lomb Inc	MACUGEN	pegaptanib sodium	INJECTABLE;INTRAVITREAL	021756-001	Dec 17, 2004	⤷ Sign Up	⤷ Sign Up
Bausch And Lomb Inc	MACUGEN	pegaptanib sodium	INJECTABLE;INTRAVITREAL	021756-001	Dec 17, 2004	⤷ Sign Up	⤷ Sign Up
Bausch And Lomb Inc	MACUGEN	pegaptanib sodium	INJECTABLE;INTRAVITREAL	021756-001	Dec 17, 2004	⤷ Sign Up	⤷ Sign Up
Bausch And Lomb Inc	MACUGEN	pegaptanib sodium	INJECTABLE;INTRAVITREAL	021756-001	Dec 17, 2004	⤷ Sign Up	⤷ Sign Up
Bausch And Lomb Inc	MACUGEN	pegaptanib sodium	INJECTABLE;INTRAVITREAL	021756-001	Dec 17, 2004	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.